Molecular Imaging group working on the Dx and Rx of cancer. Husband, Father, Scientist, Nerd. Opinions are my own. Past President @WMISWMIC and @SocRadiophSci
Joined January 2016
- Tweets 3,766
- Following 700
- Followers 2,929
- Likes 1,560
669 Photos and videos
I am thrilled to announce that I was elected to be the 2028 SNMMI President - one of the coolest things is to follow the footsteps of these 3 SNMMI Past Presidents and the next SNMMI President (in three days) Heather Jacene. @HJacene @CathyCutler1234 @SallyWSchwarz Helen Nadel
1
18
618
Jason Lewis Radiochem MSK retweeted
Final places are still available to attend the Cancer Grand Challenges Conference: Cancer and the host
If you’re interested in exploring cancer as a systemic disease and joining thought leaders from across the cancer research spectrum to discuss and debate how the unique biology of each individual shapes cancer development and treatment response, this is a meeting you won’t want to miss.
Register now to secure your place: eventbrite.co.uk/e/grand-cha…
🗓️ Wednesday 17 – Friday 19 June 2026
🚨 Registration closes Friday 1 May 2026
📍 The Royal Society, London
@MarcusDGon, Professor Caroline Dive. CBE, @diggy5353 , @giampazolias, Mariam Jamal-Hanjani, @Joycelab, @LewisLabMSKCC, @lynchielydia , Stephen o'rahilly, Marco Sandri, Erica Sloan, Claudio Vernieri, Ashani Weeraratna, @EileenWhitePhD and Frank Winkler @CR_UK @NCICancerTrials
7
7
4,084
It’s out “Trop-2.2–Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model”led by @ECharlesPratt et al aacrjournals.org/clincancerr…
2
135
Jason Lewis Radiochem MSK retweeted
MSK radiochemist @LewisLabMSKCC shared an insightful presentation about questions and new opportunities in #theranostics at #AACR26. @AACR
2
5
721
Our paper "Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix–Targeted Radiopharmaceutical against Triple-Negative Breast Cancer" is out. aacrjournals-org.eu1.proxy.o… The thesis work of @Just_Hachey. Added bonus - we got the cover of CCR!
1
4
413
Jason Lewis Radiochem MSK retweeted
Mar 31
Wonderful to see Barbara Hertz today on the 85th anniversary of Dr Saul Hertz’s first-in-human radioiodine therapy. A landmark that helped launch theranostics, and targeted precision oncology. Still, we are just at the beginning of the theranostic revolution.
2
3
16
935
Jason Lewis Radiochem MSK retweeted
Final call for abstracts! This week is the last chance to submit your abstract for the Cancer Grand Challenges Conference: Cancer and the host
cancergrandchallenges.org/co…
🚨 Submit by Friday 20 March for the opportunity to join an outstanding line-up of speakers #CancerGrandChallenges #CancerResearch
4
15
3,143
Dear SNMMI Colleagues:
My name will be on the SNNMI ballot for Vice-President Elect (SNNMI President 2028-2029). Voting starts March 30th.
If you are a member of the SNMMI, I am hoping you will consider voting for me. My platform statement will be on the ballot.
Thank you!
8
407
Jason Lewis Radiochem MSK retweeted
Mar 13
A clinically relevant roadmap for translating CLDN18.2-targeted immuno-PET and radiotherapy for patients with HER2-negative gastric cancer: ow.ly/UgsG50YpNL8.
#NuclearMedicine #RPTherapy #GastricCancer @TheZeglisLab @YJanjigianMD @LewisLabMSKCC
5
10
827
Fabulous visit to Riken in Tokyo today - and the most impressive cyclotron I have ever seen….
8
213
The “Cycletrons” (the best name ever!) raising money for an amazing cause - curing rare cancer!! @MSKCancerCenter @Equinox @Cycle4Survival
1
3
118
3
167
Read our latest - out now at EJNMMI “Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer”. rdcu.be/e6awn
5
331
Our latest “Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer” jnm.snmjournals.org/content/…
7
202
The “Cycletrons” are participating in @Cycle4Survival to raise money for rare cancer research at @MSKCancerCenter, and your support would mean so much to us. Make a 100% tax-deductible donation using the link. Thank you! secure2.convio.net/mskcc/sit…
1
114
Jason Lewis Radiochem MSK retweeted
What's next in DLL3-targeted therapy for NECs...? Maybe this...
pnas.org/doi/10.1073/pnas.25…
7
12
1,095
Jason Lewis Radiochem MSK retweeted
Proud to see our work featured: a DLL3-targeted theranostic approach from @MSKCancerCenter combining PET imaging and targeted therapy for aggressive small cell lung and neuroendocrine prostate cancers.@MSKCancerCenter @LewisLabMSKCC mskcc.org/news/new-imaging-d…
2
9
11
1,752
Jason Lewis Radiochem MSK retweeted
Very proud to share our full discovery campaign identified a next-generation DLL3 antibody that outperformed first-gen antibodies in imaging and therapy with minimal toxicity. Huge thanks to our incredible co-authors and @PCFnews for making this possible!
pnas.org/doi/10.1073/pnas.25…
2
4
17
1,945